Sr Director, Clinical Development (MD)
Gilead Sciences
Summary
The Senior Medical Director provides clinical oversight to one or more clinical trials. Additionally, the Senior Director guides the project teams to design and implement clinical studies at high quality and in a time and cost-effective manner in line with the department and corporate goals and within regulatory and resource guidelines.
Job description
Job Responsibilities
- Provide clinical oversight and medical monitoring to one or more clinical trials
- Lead project teams to design and implement clinical studies
- Write protocols, investigator brochures, clinical study reports and review clinical trial documents
- Conduct investigator meetings and lead site initiation visits with clinical trial investigators
- Implement and deploy drug development strategic plans, develop contingency plans, provide technical and strategic advice, and meet milestones and budgets
- Translate findings from research and nonclinical studies into clinical development opportunities
- Interact with clinical investigators and thought leaders
- Work with internal regulatory affairs team and other ethical guidelines relevant to the pharmaceutical industry, and ensure compliance with these external guidelines
- Work with internal pre-clinical scientists, translational scientists, business and commercial organizations in a cross functional manner
- Work in a team environment comprising clinical operations, biomarker specialists, CROs, and regulatory affairs
- Provide clinical expertise and input for regulatory filings (i.e., BLA, MAA) as well as response to questions from regulatory authorities in the context of IND submissions, clinical trial applications or filing procedures
- Provide clinical guidance and work in a team environment in interactions with external stakeholders (medical experts, advisory boards, patient advocacy groups) and internal stakeholders (Research, Translational Sciences, Clinical Operations, Safety, Regulatory, Medical Affairs, and Commercial)
- May present scientific information at scientific conferences as well as clinical study investigator meetings. Where applicable, takes a lead on authoring scientific publications
- May assist in the clinical evaluation of business development opportunities
Basic Qualifications
MD/DO and 6+ years of clinical research or drug development experience
Preferred Qualifications
- Board certification/specialization in neurology and experience managing phase 1-3 trials; late stage experience is preferred
- 4+ years of relevant drug development experience, either within industry or as a clinical investigator/physician scientist in academia, or equivalent experience; drug development experience in neurological diseases including neuro autoimmune diseases are highly desired
- Demonstrated clinical development strategist with experience designing, implementing and conducting clinical trials, with emphasis on proof-of-concept and first-in-human studies
- Strategic leadership and tactical skills, excellent initiative and judgment
- Demonstrated ability to develop and maintain excellent working relationships with both internal colleagues and external contacts, including key thought leaders, and investigators
- Demonstrated ability to work well in teams in a cross functional manner
- Ability to communicate and work in a self-guided manner with scientific/technical personnel
- Ability to think critically, and demonstrated troubleshooting and problem-solving skills
- Self-motivated and willing to accept responsibilities outside of initial job description
- Comfortable in a dynamic small company environment with minimal direction and able to adjust workload based upon changing priorities
- May travel up to 25%
People Leader Accountabilities
- Create Inclusion - knowing the business value of diverse teams, modeling inclusion, and embedding the value of diversity in the way they manage their teams.
- Develop Talent - understand the skills, experience, aspirations and potential of their employees and coach them on current performance and future potential. They ensure employees are receiving the feedback and insight needed to grow, develop and realize their purpose.
- Empower Teams - connect the team to the organization by aligning goals, purpose, and organizational objectives, and holding them to account. They provide the support needed to remove barriers and connect their team to the broader ecosystem.
Requirements
- MD/DO degree
- 6+ years of clinical research or drug development experience
- Board certification/specialization in neurology
- Experience managing phase 1-3 trials
- 4+ years of relevant drug development experience
- Experience in neurological diseases including neuro autoimmune diseases
- Experience designing, implementing and conducting clinical trials
- Experience with proof-of-concept and first-in-human studies
- Strategic leadership and tactical skills
- Ability to develop and maintain working relationships
- Ability to work in cross functional teams
- Ability to communicate with scientific/technical personnel
- Critical thinking and problem-solving skills
- Self-motivated and adaptable
- May travel up to 25%
Benefits
- Medical, Dental & Vision
- Life Insurance
- Paid Time Off
- Annual Bonus
- Stock-Based Long-Term Incentives
Company overview
Gilead Sciences, Inc. is a leading American biopharmaceutical company headquartered in Foster City, California, that specializes in researching, developing, and commercializing innovative medicines for life-threatening diseases. Founded in 1987, Gilead has grown into a global healthcare leader with approximately 17,600 employees worldwide. The company's primary therapeutic focus areas include HIV/AIDS, viral hepatitis (hepatitis B and C), oncology, inflammation, and respiratory diseases. Gilead is renowned for its groundbreaking antiviral therapies, including Sovaldi and Harvoni for hepatitis C, and its comprehensive portfolio of HIV treatments such as Truvada, Atripla, and Biktarvy. The company also developed Veklury (remdesivir) for COVID-19 treatment. Gilead operates as a publicly traded company on the NASDAQ (GILD) and is a component of both the Nasdaq-100 and S&P 100 indices. Through strategic acquisitions like Kite Pharma and Immunomedics, Gilead has expanded into cell therapy and oncology, demonstrating its commitment to advancing medical science and improving patient outcomes globally.